Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients. Knutson, Keith L.; Schiffman, Kathy; Disis, Mary L. [Miscellaneous Article] Journal of Clinical Investigation. 107(4):477-484, February 2001.
(Format: HTML)
